Campbell moved fast. He held a press conference right away and confirmed the details Young-Joon announced during the cancer conference.0

“The U.S. government provided three billion dollars in annual funding to help Doctor Ryu Young-Joon, the CEO of A-Bio, build the A-Bio Cancer Laboratory,” Campbell said. “The A-Bio Cancer Laboratory is an affiliate company of the National Institute of Health, and it will have access to all anticancer research data at the National Cancer Institute, and the National Center for Biotechnology Information.”0

Even if the corporation itself followed U.S. laws, it was still a foreign company. Plus, it was highly unusual for the U.S. government to give them this much access. And frankly, the fact that they were giving him three billion dollars was just insane.1

“Furthermore, the U.S. government has decided not to claim any rights to any new drugs developed from it,” Campbell said. “The A-Bio Cancer Laboratory was controversial from the beginning of its establishment. People were asking why America should spend so much tax money to help a foreign company get off the ground....0